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Abstract: 
While colonoscopy is the most prevalent screening test for colorectal cancer (CRC), it is often 
too expensive, too uncomfortable, or too time-consuming for patients. Non-compliance is 
common.  Recently, fecal immunochemical testing (FIT) has become a guideline-recommended 
alternative. The FIT is a non-invasive, inexpensive method that requires no uncomfortable 
preparation by patients.  The decision to recommend the colonoscopy or the FIT is based on the 
patient’s estimated risk for CRC.  
Several countries have created risk prediction tools to help identify patients at high risk for 
advanced colorectal neoplasia (the combination of CRC and advanced, precancerous polyps). A 
U.S.-based prediction tool was recently published1 that uses five easily and reliably measured 
factors (age, sex, a first degree relative with CRC, waist circumference, and cigarette smoking 
history) to quantify risk. We aimed to learn the impressions of clinicians and patients to this risk 
estimation tool. 
In the first phase of this study, we used a semi-structured format to interview clinicians at a VA 
medical center and a non-VA hospital. Using a paper prototype of the risk estimation tool, we 
asked about its usefulness to estimate risk and to aid their selection of a CRC screening tool. 
Using a grounded theory approach, we analyzed the interview transcripts and identified major 
themes. We found that clinicians thought the tool was clear and easy to use.  However, they are 
unlikely to use it as a decision aid until FIT is more widely-endorsed as an acceptable alternative 
screening test. In phase two of the study, we will interview patients to assess their responses to 
the tool.  
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